Lead Poisoning Agents

While not formalized as a distinct pharmacological class name by the FDA, "lead poisoning agents" is a functional clinical grouping referring to chelating antidotes used to manage lead toxicity These medications—predominantly succimer, edetate calcium disodium (calcium EDTA), and dimercaprol (British anti-Lewisite)—act by chemically binding circulating and soft-tissue lead ions to form stable, non-toxic, water-soluble complexes Once chelated, the bound metal is eliminated from the body via urina...

While not formalized as a distinct pharmacological class name by the FDA, "lead poisoning agents" is a functional clinical grouping referring to chelating antidotes used to manage lead toxicity Their primary therapeutic role is in the treatment of acute or chronic lead poisoning with significantly elevated blood lead levels, including cases complicated by lead-induced encephalopathy, in pediatric and adult populations

These medications—predominantly succimer, edetate calcium disodium (calcium EDTA), and dimercaprol (British anti-Lewisite)—act by chemically binding circulating and soft-tissue lead ions to form stable, non-toxic, water-soluble complexes Once chelated, the bound metal is eliminated from the body via urinary or biliary excretion, thereby reducing systemic burden and preventing further cellular and organ damage